Insider Stock Trading History of Douglas Earl Martin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Douglas Earl Martin since year 2005. The trader's CIK number is 1362155. At the time of this reporting, Douglas Earl Martin is the General Counsel of Biomimetic Therapeutics, Inc. . (stock ticker symbol BMTI). See this page for all insider trading activities at Biomimetic Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Douglas Earl Martin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2012-03-26 BMTI Biomimetic Therapeutics, Inc. Sale 1,100 2.35 2,585
2012-03-27 BMTI Biomimetic Therapeutics, Inc. Sale 5,000 2.34 11,700
2012-03-28 BMTI Biomimetic Therapeutics, Inc. Sale 47,461 2.35 111,533
2011-10-14 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 3.06 9,165
2011-10-13 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 2.98 8,943
2011-10-12 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 2.99 8,970
2011-10-06 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 2.99 8,964
2011-10-07 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 3.02 9,045
2011-10-10 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 2.97 8,910
2011-10-11 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 3.00 9,015
2011-10-04 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 2.89 8,679
2011-10-05 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 2.94 8,835
2011-10-03 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 2.92 8,757
2010-03-17 BMTI Biomimetic Therapeutics, Inc. Option Ex 25,500 3.63 92,565
2010-03-17 BMTI Biomimetic Therapeutics, Inc. Sale 5,000 13.30 66,500
2010-01-13 BMTI Biomimetic Therapeutics, Inc. Sale 12,799 12.12 155,123
2010-01-02 BMTI Biomimetic Therapeutics, Inc. Option Ex 34,000 3.63 123,420
2010-01-13 BMTI Biomimetic Therapeutics, Inc. Option Ex 37,000 3.63 134,310
2009-03-17 BMTI Biomimetic Therapeutics, Inc. Sale 1,200 8.45 10,140
2008-04-14 BMTI Biomimetic Therapeutics, Inc. Option Ex 8,500 3.63 30,855
2008-03-28 BMTI Biomimetic Therapeutics, Inc. Buy 1,000 9.05 9,050
2008-01-23 BMTI Biomimetic Therapeutics, Inc. Buy 3,500 15.24 53,329

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Douglas Earl Martin (General Counsel of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.